Use the search parameters below to filter talks:

2010 - TTS International Congress (Vancouver)

Access to Treatment and Quality of Life
16 August 2010  /  15:30 - 16:59
Clinical and socio-demographic determinants of utility among patients with renal transplantation
Presenter: Zoltan Kalo, Hungary

Biologic and Therapeutic Advances in Heart Transplantation I
16 August 2010  /  15:30 - 16:59
Initiation of Everolimus with Calcineurin Inhibitor (CNI) Minimization in Thoracic Transplant Patients with Impaired Renal Function: 24 Months Follow-up of a Multicenter, Randomized Study
Presenter: Lars Gullestad, Norway
Cardiac Transplant Candidates with LVAD may have Circulating Level of HLA-Specific Natural Antibodies
Presenter: Afzal Nikaein, United States
Effect of Conversion From Calcineurin Inhibitors (CNIs) to Sirolimus on Renal Function in Cardiac Transplant Recipients With Mild to Moderate Renal Insufficiency: Interim Safety and Efficacy Results
Presenter: Maria Crespo-Leiro, Spain
Emergency Heart Transplantation Outcome: the Italian Experience
Presenter: Carlo De Cillia, Italy
Incidence of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices as a bridge to cardiac transplantation: HeartMate XVE versus HeartMate II
Presenter: Alykhan Nagji, United States
Effects of Donor Pretreatment with Dopamine on Graft Function after Heart Transplantation: Data from a randomized controlled trial.
Presenter: Urs Benck, Germany
Patients on long-term betaceptor-antagonist treatment with peak oxygen consumption above the cut-off point for heart transplantation listing have worse survival if a restrictive pattern in lung function tests occures
Presenter: Maria Lizak, Poland
Incidence and Management of Surgical Wound Complications in De Novo Heart Transplant Recipients Treated with Everolimus
Presenter: Markus Barten, Germany
Donor Selection by Virtual Crossmatching for Sensitized Heart Transplant Patients
Presenter: Dong-Feng Chen, United States

The Problem of Viral Hepatitis in Liver Transplantation
16 August 2010  /  15:30 - 16:59
Effect of MDR1 and ABCG8 polymorphisms on hepatitis C recurrence following liver transplantation
Presenter: Speranta Iacob, Romania
Factors Affecting Recurrence of Hepatitis C after Liver Transplantation—Correlation with Histology on Protocol Liver Biopsies.
Presenter: Greg McKenna, United States
Hepatitis C (HCV)-3 Study: Lessons Learned From a Multicenter Liver Transplantation (OLT) Trial.
Presenter: Goran Klintmalm,
Limiting HCV Progression in Transplant Recipients Through Conversion to Sirolimus Based Immunosuppression
Presenter: Greg McKenna, United States
Donor Risk Index and Associated Donor Variables May Influence Serum Hepatitis C Viral Load
Presenter: Tanya Flohr, United States
The impact of Sirolimus based immunosuppression on response to anti-HCV therapy after liver transplantation
Presenter: Sonal Asthana, Canada

Options and Outcomes in the Sensitized Kidney Recipient
16 August 2010  /  15:30 - 16:59
Rapid Expansion of Live Donor Kidney Transplantation at a Single Center Using Kidney Paired Donation
Presenter: Adam Bingaman, United States
Long-term outcome according to levels of preformed donor-specific HLA-antibodies in kidney transplantation
Presenter: Carmen Lefaucheur, France
Combined Liver-Kidney Transplants: Do Livers Always Protect Kidneys in Allosensitized Recipients?
Presenter: Medhat Askar, United States
Proteasome Inhibition Depletes Alloantibody-Secreting Plasma Cells and Improves Efficacy of Plasma Exchange in Highly Sensitized Renal Allograft Candidates
Presenter: Mark Stegall, United States

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada

Info

Privacy Policy
Terms of Use
Copyright Notice